Both sides of the litigation recently presented key scientific evidence during a science day session
Swarts BM Bioorthogonal Chemical Reporters for Selective In Situ Probing of Mycomembrane Components in Mycobacteria
Our understanding of the long-term safety of GLP-1 agonists remains limited, a concern that is particularly pertinent for chronic conditions such as pain and headaches
If your practice compounds or administers non-commercial formulations, now is the time for a legal compliance check-up.
Supplement Facts: Serving Size: 2.25g Servings Per Container: 120 Amount Per Serving: Beta-alanine: 800 mg Citrulline malate: 375 mg (of which citrulline 250 mg) Betaine: 250 mg Creatine monohydrate: 125 mg (of which creatine 110 mg) L-tyrosine: 125 mg Choline bitartrate: 125 mg (of which choline 51.25 mg) Caffeine: 100 mg Vitamin B6: 4.5 mg (321% RI) Niacin: 4 mg NE (25% RI) *RI - Reference Intake Ingredients: Beta-alanine, citrulline malate, betaine anhydrous, creatine monohydrate, L-tyrosine, choline bitartrate, anti-caking agent (E551), flavours, caffeine anhydrous, acidity regulators (E330, E296), vitamin B6 (pyridoxine hydrochloride), niacin (nicotinic acid), salt, beetroot juice concentrate, black carrot concentrate, sweeteners (acesulfame K, sucralose, steviol glycosides from stevia), colours (E160a, E104, E132)
The EC50 of GLP1 (7-36) is in the expected 2 digits pM range (25-60pM), while its metabolite shows a potency which is 4 logs lower and falls into the low M range